Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria
Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare ...
YOUR HEALTH: Kids and their battles with kidney stones
It’s just a big mass,” said Alex’s mom, Kate. Alex was born with a genetic disease called Cystinuria. “Your body doesn’t ...
Morningstar2d
Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria
As previously stated, the company has engaged in a new round of discussions with the US FDA to finalize the development plan for ADV7103 in cystinuria in the United States. During the latest ...